4.4 Review

Penicillin allergy delabeling Opportunities for implementation and dissemination

Journal

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
Volume 130, Issue 5, Pages 554-564

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.anai.2022.12.023

Keywords

-

Ask authors/readers for more resources

Unconfirmed penicillin allergy labels have negative impact on personal and public health, leading to the emergence and transmission of resistant bacteria. Efforts have been made to promote proactive penicillin allergy evaluations and delabeling to remove inaccurate allergy labels. Access to penicillin allergy evaluation services is limited, but recent studies show the feasibility of expanding these services to a wider range of healthcare professionals.
Although existing as a safety measure to prevent iatrogenic harm, unconfirmed penicillin allergy labels have a negative impact on personal and public health. One downstream effect of unconfirmed penicillin allergy is the continued emergence and transmission of resistant bacteria and their associated health care costs. Recognizing the consequences of inaccurate penicillin allergy labels, professional and public health organizations have started promoting the adoption of proactive penicillin allergy evaluations, with the ultimate goal of removing the penicillin allergy label when the allergy is disproved, also known as penicillin allergy delabeling. A penicillin allergy evaluation includes a comprehensive allergy history often followed by drug challenge, sometimes with preceding skin testing. Currently, penicillin allergy delabeling is largely carried out by allergy specialists in outpatient settings. Penicillin allergy delabeling is performed on inpatients, albeit rarely, often at the time of need, as a point-of-care procedure. Access to penicillin allergy evaluation services is limited. Recent studies demonstrate the feasibility of expanding penicillin allergy evaluations and delabeling to internists, pediatricians, emergency medicine physicians, infectious diseases specialists, and clinical pharmacists. However, reducing the impact of mislabeled penicillin allergy will require comprehensive efforts and new investments. In this review, we summarize the current practices of penicillin allergy delabeling and discuss expansion opportunities for penicillin allergy delabeling as quality improvement. & COPY; 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available